Skip to content
Offline

Aurinia Pharmaceuticals Inc

🇩🇪XFRA.IKAPGermanyHealthcare

€13.88EURdown -0.09 (-0.64%)OpenEnd of day7:52 PM
OverviewAnalysisbetaPrice ChartFinancialsRevenue StreamsNot available for this exchange yetAnomaliesNewsNot available for this exchange yetInvestorsNot available for this exchange yetCorporate Actions

Price€13.88-0.09 (-0.64%)

Profile

  • Healthcare
  • Biotechnology
  • Germany

Identity

Exchange
Frankfurt Stock Exchange . XFRA
Type
Stock
ISIN
CA05156V1022
CUSIP
Not reported

Company

Employees
128
Headquarters
Edmonton, United States
Website
https://www.auriniapharma.com
CEO
Mr. Kevin C. Tang

Market

Shares outstanding
133M
Market cap
€1.85B

Highlights

Day range€13.88 - €13.95
today's session
52-week range€9.17 - €16.40
from 252 sessions
Market cap
€1.85B
EPS LTM
$2.36calculatedCalculated by Finzer, not reported by the data provider.
P/E LTM
Not reported
Div yield
Not reported

Fundamentals (LTM)

Revenue
$311.51M+19.76%up year on year
Net income
$314.11M+418.03%up year on year
Gross margin
90.36%+0.94%up year on year
Free cash flow
$173.58M+87.8%up year on year

View all financials

Other listings

These are the venues Finzer covers, not every venue that exists.

Business summary

No company summary reported yet.

Cookies and analyticsWe measure how the site is used. Without your agreement we count you anonymously and store nothing on your device. Accept to let us link that to your account, so we can improve what you actually use. We never send personal data either way.We count visits anonymously. Accept to link them to your account. Privacy Policy